Medscheme appoints Kevin Aron as CEO
09 June 2014 | People and Companies | Appointments | Medscheme
Kevin Aron has been appointed Medscheme’s CEO with effect from the beginning of July. Medscheme, which is a wholly owned subsidiary of AfroCentric Health Limited, is one of South Africa’s largest medical scheme administrators and health risk managers.
Aron, who served as MD of Medscheme South Africa until his appointment is now responsible for Medscheme’s South African, African and international operations.
"Having built an excellent rapport with both clients and employees during his tenure at Medscheme thus far, I have no doubt Kevin will continue to have a profoundly positive impact on the Group,” said Dr Anna Mokgokong, chairman of Afrocentric Investment Corporation.
"We are confident that with his extensive knowledge of the company, the industry and the markets we serve provides an exceptional foundation from which to build on the successes Medscheme has achieved to date,” she added.
A qualified Chartered Accountant, Aron completed his articles with Ernst & Young and holds an MBA from Henley in the United Kingdom.
Before joining Medscheme in 2001, Aron was employed as a management accountant at SA Druggists and as New Business Development Manager at Healthcare Management Services. He then moved to Medical Services Organisation where he was appointed Financial Director and rose to the position of Chief Operating Officer. A stint at Investec followed.
"I am deeply honoured to accept this appointment and humbled by confidence placed in me by the board.
It is exciting to be given the opportunity to lead Medscheme at this particular time. The company’s well-deserved reputation for customer centricity and operational efficiencies places us in a great position to take advantage of the opportunities in the healthcare sector,” he said.
Aron takes over the position from André Meyer, who left at the beginning of this year. Wallace Holmes, the group’s CFO has been in an acting CEO role since Meyer’s departure.
